NF1 and Down syndrome: Consequently, OGM presents a powerful technique to identify and classify type-1 NF1 deletions in particular in patients who do not exhibit all clinical features frequently associated with NF1 microdeletion syndrome or in patients that are quite young and may not, as yet, clearly exhibit the full phenotypic spectrum of the disease manifestations.